SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-23-029023
Filing Date
2023-03-06
Accepted
2023-03-06 16:22:29
Documents
7
Effectiveness Date
2023-03-06

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm238203d1_s8.htm S-8 38728
2 EXHIBIT 5.1 tm238203d1_ex5-1.htm EX-5.1 18717
3 EXHIBIT 23.1 tm238203d1_ex23-1.htm EX-23.1 2863
4 EX-FILING FEES tm238203d1_ex-filingfees.htm EX-FILING FEES 11475
5 GRAPHIC tm238203d1_ex5-1image001.jpg GRAPHIC 5476
6 GRAPHIC tm238203d1_ex5-1image002.jpg GRAPHIC 2504
7 GRAPHIC tm238203d1_ex5-1image003.jpg GRAPHIC 2504
  Complete submission text file 0001104659-23-029023.txt   87981
Mailing Address 350 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 350 TECHNOLOGY DRIVE PITTSBURGH PA 15219 412-763-3350
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: S-8 | Act: 33 | File No.: 333-270300 | Film No.: 23709237
SIC: 2834 Pharmaceutical Preparations